
Magritek
Founded by Sir Paul Callaghan, Magritek makes benchtop nuclear magnetic resonance (NMR) solutions, measuring the chemical properties of substances for research and industry.
As a world leader in the field, Magritek brought the first desk top NMR spectrometer to the market in 2012.
Rangatira is invested alongside management, employees, Ampersand Capital (US healthcare tech investor) and other shareholders. In 2023, Ampersand increased their stake to 20%.
Investment Date 2013
Ownership Interest 24%
Primary Contact Mark Dossor